Page 4 - Tff Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tff pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tff Pharmaceuticals Today - Breaking & Trending Today

Short Interest in TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Expands By 37.6%

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP – Get Rating) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 209,200 shares, an increase of 37.6% from the March 31st total of 152,000 shares. Based on an average daily volume of 164,500 shares, the short-interest ratio is […] ....

United States , Harlanf Weisman , Sigma Planning Corp , Tff Pharmaceuticals Inc , Pharmaceuticals Daily , Virtu Financial , Pharmaceuticals Inc , Pharmaceuticals Trading , Securities Exchange Commission , Get Rating , Exchange Commission , Street Corp , Planning Corp , Thin Film Freezing , Tff Pharmaceuticals , Nasdaq Tffp ,

TFF Pharmaceuticals (NASDAQ:TFFP) Coverage Initiated by Analysts at Jonestrading

Jonestrading started coverage on shares of TFF Pharmaceuticals (NASDAQ:TFFP – Get Rating) in a research report released on Wednesday, Benzinga reports. The firm issued a buy rating and a $7.00 target price on the stock. Separately, HC Wainwright reissued a buy rating and set a $22.00 target price on shares of TFF Pharmaceuticals in a […] ....

United States , Harlanf Weisman , Pharmaceuticals Inc , Pharmaceuticals Daily , Pharmaceuticals Company Profile , Vanguard Group Inc , Capital Management , Securities Exchange Commission , Pharmaceuticals Stock Down , Millennium Management , Get Rating , Stock Down , Exchange Commission , Thin Film Freezing , Tff Pharmaceuticals , Nasdaq Tffp , Initiated Coverage ,

TFF Pharmaceuticals (NASDAQ:TFFP) Earns Buy Rating from Analysts at Jonestrading

Jonestrading initiated coverage on shares of TFF Pharmaceuticals (NASDAQ:TFFP – Get Rating) in a research report report published on Wednesday morning, Benzinga reports. The firm issued a buy rating and a $7.00 price objective on the stock. Separately, HC Wainwright restated a buy rating and issued a $22.00 target price on shares of TFF Pharmaceuticals […] ....

United States , Harlanf Weisman , Pharmaceuticals Trading Down , Pharmaceuticals Daily , Securities Exchange Commission , Sigma Planning Corp , Virtu Financial , Renaissance Technologies , Quantum Private Wealth , Pharmaceuticals Inc , Get Rating , Trading Down , Exchange Commission , Sigma Investments , Private Wealth , Planning Corp , Thin Film Freezing , Tff Pharmaceuticals , Nasdaq Tffp , Initiated Coverage ,